The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerance of topical cidofovir (HPMPC) therapy for condyloma
acuminatum in patients with HIV infection. To investigate whether topical HPMPC therapy can
induce regression of condyloma acuminatum in patients with HIV infection.